Changes in Bone Mineral Density During and After Lactation in Ugandan Women With HIV on Tenofovir‐Based Antiretroviral Therapy-Reference-Cited by-同舟云学术

Changes in Bone Mineral Density During and After Lactation in Ugandan Women With HIV on Tenofovir‐Based Antiretroviral Therapy

Published:2020-08-26 Issue:11 Volume:35 Page:2091-2102
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Nabwire Florence¹^ORCID,Prentice Ann¹,Hamill Matthew M¹^ORCID,Fowler Mary Glenn²,Byamugisha Josaphat³,Kekitiinwa Adeodata⁴,Goldberg Gail R¹

Affiliation:

1. MRC Nutrition and Bone Health Research Group Cambridge UK

2. MUJHU Care Ltd Kampala Uganda

3. Makerere University Kampala Uganda

4. Baylor College of Medicine Children's Foundation Uganda (Baylor‐Uganda) Kampala Uganda

Funder

Gates Cambridge Trust

University of Cambridge

Alborada Trust

Department for International Development, UK Government

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4121

Reference32 articles.

1. Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

2. Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

3. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

4. Tenofovir and bone health

5. World Health Organization. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. HIV/AIDS Programme.Geneva Switzerland:World Health Organization;2012. p. 7.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential;Expert Review of Anti-infective Therapy;2024-03-27

3. Biochemical Markers of Calcium and Bone Metabolism during and after Lactation in Ugandan Women with HIV on Universal Maternal Antiretroviral Therapy;Journal of Bone and Mineral Research;2023-07-24

4. Milk Calcium and Phosphorus in Ugandan Women with HIV on Tenofovir-Based Antiretroviral Therapy;Journal of Human Lactation;2023-01-30

5. Gender and sex considerations in HIV and bone health;Current Opinion in HIV and AIDS;2023-01-09